This inventor holds 6 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: Bayer Aktiengesellschaft. Active years: 2018-2023.
Location History:
- Köln, DE (2018 - 2020)
- Cologne, DE (2019 - 2023)
Company Filing History:
Years Active: 2018-2023
Title: Martin Lobedann: Innovator in Viral Clearance Technology
Introduction
Martin Lobedann is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of viral clearance technology, holding a total of 6 patents. His work focuses on innovative methods and devices that enhance the safety and efficiency of processes involving biological materials.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Unit operation and use thereof." This invention provides a unit operation formed by a device designed for continuous virus inactivation of a continuous flow of a process fluid. The unit operation comprises a single inlet at one end and an outlet at the opposite end, featuring at least one High-Frequency Inactivation (HFI) installation. This innovative design aims to improve the safety of processes that handle potentially infectious materials. Another significant patent is related to the "Validation of continuous viral clearance," which outlines a method for validating the effectiveness of continuous viral clearance. This method includes steps such as providing a probe, spiking it in a valid manner, performing viral clearance, and analyzing the sample.
Career Highlights
Martin Lobedann is currently employed at Bayer Aktiengesellschaft, a leading global company in the life sciences sector. His role involves developing and implementing advanced technologies that contribute to public health and safety. His expertise in viral clearance has positioned him as a key player in the industry.
Collaborations
Throughout his career, Martin has collaborated with talented professionals, including Peter Schwan and Laura David. These collaborations have fostered innovation and have led to the successful development of new technologies in the field.
Conclusion
Martin Lobedann's contributions to viral clearance technology exemplify his commitment to enhancing safety in biological processes. His innovative patents and collaborations with industry professionals continue to make a significant impact in the field.